Health & Fitness
NYU Langone's Coronavirus Vaccine Trial Expands To Brooklyn
The hospital network has opened a vaccine center at its Brooklyn and Long Island locations and is looking for people to join a trial.
BROOKLYN, NY — One of the frontrunners in the search for a coronavirus vaccine is expanding its trial to Brooklyn.
NYU Langone hospital network announced this week that it has opened two new Vaccine Center locations in Brooklyn and Long Island in order to expand enrollment in clinical trials of vaccines and experimental treatments for COVID-19. The Brooklyn location is found at its hospital on 55th Street.
The new spots will help enroll the 30,000 total patients needed to try out an experimental vaccine developed by AstraZeneca, one of the pharmaceutical companies in the race to get U.S. approval for a coronavirus vaccine.
Find out what's happening in Park Slopefor free with the latest updates from Patch.
It aims to bring the vaccine trial and other medical research to those underrepresented in clinical trials, but at higher risk of COVID-19 infection, including Black, Hispanic and elderly people, according to the company.
“The expansion of the vaccine center into Brooklyn is an enormous opportunity and will have a meaningful impact in the global effort to develop a COVID-19 vaccine,” said Stephanie Sterling, a co-leader of the new Brooklyn research clinic. "Diversity in clinical trial enrollment is critical to ensuring the safety and efficacy of a vaccine, and we are grateful to have wonderful community partners in Brooklyn to help bring an end to this international public health crisis.”
Find out what's happening in Park Slopefor free with the latest updates from Patch.
AstraZeneca is looking to enroll 30,000 patients across the globe between the ages of 18 and 85 to receive two doses of either the vaccine or a placebo saline solution.
The news of the Brooklyn trial comes as another company in search of the vaccine, Pfizer, announced promising results about its nearly-completed human trials this week. Pfizer and AstraZeneca are both in a group of 11 companies that have reached phase three of their trial process.
NYU Langone Health is one of 10 specialized National Institutes of Health-funded Vaccine and Treatment Evaluation Units, or VTEUs, in the nation. As a VTEU, NYU Langone Health is part of the COVID-19 Prevention Network (CoVPN), supported by the National Institute of Allergy and Infectious Diseases (NIAID).
To express interest in COVID-19 vaccine trial enrollment or learn more, click here.
Get more local news delivered straight to your inbox. Sign up for free Patch newsletters and alerts.
